AMPK signaling has been reported to be both beneficial and deleterious in amyotrophic lateral sclerosis (ALS), a neurodegenerative disease in which Sephin1 has been shown to be effective, and is still undergoing a controversial claims [69]. The gene discussed is PRKAA1; the disease is amyotrophic lateral sclerosis.